49 results
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
28 Jan 22
BrainStorm Cell Therapeutics Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
4:10pm
and Clinical Innovation
Conference call and webcast at 8:00 a.m. Eastern Time today
NEW YORK, Nov. 15, 2021 -- BrainStorm Cell Therapeutics Inc. (NASDAQ … and Medical Affairs and Kim Thacker, MD, as Senior VP, Medical Affairs and Clinical Innovation.
Drs. Spector and Thacker will work together to create
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
12 Dec 12
BrainStorm Receives 3 Million NIS Grant
12:00am
of fostering economic growth, encouraging technological innovation and entrepreneurship, leveraging Israel's scientific potential, enhancing
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
4 Apr 05
Departure of Directors or Principal Officers
12:00am
in the financing, business growth and development of
multiple companies. His expertise varies from technological innovation through
strategic planning
8-K
EX-99.1
BCLI
Brainstorm Cell Therapeutics, Inc.
16 Apr 24
BrainStorm Cell Therapeutics Announces Management Changes as Company Plans Registrational Phase 3b Trial of NurOwn
9:31pm
of leading successful clinical trials and fostering innovation in drug development. Prior to joining Brainstorm he was Chief Medical Officer at Enveric
8-K
EX-99.1
n1upobrauh q3b
16 May 22
BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update
7:16am
8-K
EX-99.1
s0c p79df7mrb3y86ig
28 Mar 22
BrainStorm Cell Therapeutics Announces Full Year 2021 Financial
7:15am
8-K
EX-99.1
8n62um4hq
15 Aug 22
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update
7:22am